Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment

Human Gene Therapy

Volumn 7, Issue 16, 1996, Pages 1989-1994

  Kramm, Christof M ^a,b,c   Rainov, Nikolai G ^a,b,d   Sena Esteves, Miguel ^a,b   Barnett, Faith H ^a,b,e   Chase, Maureen ^a,b   Herrlinger, Ulrich ^a,b   Pechan, Peter A ^a,b   Chiocca, E Antonio ^a,b   Breakefield, Xandra O ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; RIBONUCLEOTIDE REDUCTASE; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER SURVIVAL; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISSEMINATED CANCER; EXPRESSION VECTOR; GENE THERAPY; GLIOSARCOMA; HERPES SIMPLEX VIRUS 1; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LEPTOMENINX; MALE; NONHUMAN; RAT;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; RODENTIA;

EID: 0029818276     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.16-1989     Document Type: Article

References (17)

1. ANDERSON, W.F., MILLER, A.D., and BORDIGNON, C., eds. (1995). ORDA reports. Recombinant DNA Advisory Committee (RAC). Data management report - December 1994. Hum. Gene Ther. 6, 535-548.
2. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
3. BARINGER, J.R., and PISANI, P. (1994). Herpes simplex virus genomes in human nervous system tissues analyzed by polymerase chain reaction. Ann. Neurol. 36, 823-829.
4. BOVIATSIS, E.J., CHASE, M., WEI, M., TAMIYA, T., HURFORD, R.K. JR., KOWALL, N.W., TEPPER, R.I., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994a). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus (HSV), and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
5. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994b). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54, 5745-5751.
6. BREAKEFIELD, X.O., KRAMM, C.M., CHIOCCA, E.A., and PECHAN, P.A. (1995). Herpes simplex virus vectors for tumor therapy. In The Internet Book of Gene Therapy. Cancer Therapeutics. R.E. Sobol and K.J. Scanlon, eds. (Appleton & Lange, Stamford, CT) pp. 41-56.
7. COHEN, M.E., and DUFFNER, P.K. (1994). Brain Tumors in Children. Principles of Diagnosis and Treatment, 2nd ed. (Raven Press, New York).
8. GOLDSTEIN, D.J., and WELLER, S.K. (1988). Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62, 196-205.
9. KRAMM, C.A., RAINOV, N.G., SENA-ESTEVES, M., CHASE, M., PECHAN, P.A., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1996). Herpes vector-mediated delivery of marker genes to disseminated CNS tumors. Hum. Gene Ther. 7, 291-300.
10. MAHALEY, M.S., JR., BROOKS, W.H., and ROSZMAN, T.L. (1977). Immunobiology of primary intracranial tumors. I. Studies of the cellular and humoral immune competence of brain tumor patients. J. Neurosurg. 46, 467-476.
11. MARTUZA, R.L., MALICK, A., MARKERT, J.M., RUFFNER, K.L., and COEN, D.M. (1991). Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252, 854-856.
12. MINETA, T., RABKIN, S.D., YAZAKI, T., HUNTER, W.D., and MARTUZA, R.L. (1995). Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med. 1, 938-943.
13. OLDFIELD, E.H., RAM, Z., CHIANG, Y., and BLAESE, R.M. (1995). Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108. A phase I/II study. Hum. Gene Ther. 6, 55-85.
14. RAINOV, N.G., ZIMMER, C., CHASE, M., KRAMM, C.M., CHIOCCA, E.A., WEISSLEDER, R., and BREAKEFIELD, X.O. (1995). Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum. Gene Ther. 6, 1543-1552.
15. RAM, Z., WALBRIDGE, S., OSHIRO, E.M., VIOLA, J.J., CHIANG, Y., MUELLER, S.N., BLAESE, R.M., and OLDFIELD, E.H. (1994). Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res. 54, 2141-2145.
16. TURNER, D.L., SNYDER, E.Y., and CEPKO, C.L. (1990). Lineage-independent determination of cell type in the embryonic mouse retina. Neuron 4, 833-845.
17. WEIZSAECKER, M., DEEN, D.F., ROSENBLUM, M.L., HOSHINO, T., GUTIN, P.H., and BARKER, M. (1981). The 9L rat brain tumor: description and application of an animal model. J. Neurol. 224, 183-192.